CVE-2026-21980 json
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform).
published 2026-01-20 9 mo ago modified 2026-06-17 4 mo ago also EUVD-2026-3532
- cvss
- 6.5
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.2%
- EPSS 0.2% chance of exploitation in 30 days, percentile 12%
- public exploits
- 0
- none known
Summary
Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).
CISA SSVC
- Exploitation
- none
- Automatable
- yes
- Technical impact
- partial
- Assessed
- 9 mo ago
Exploit prediction
0.22% chance of exploitation in the next 30 days, higher than 12% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CNA | 3.1 | 6.5 | CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N |
Affected products
- Oracle Corporation Oracle Life Sciences Central Coding
References
-
oracle.com
/security-alerts/cpujan2026.html
vendor-advisory
Sources
- CVE List CVE-2026-21980
- NVD CVE-2026-21980
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.